Cited by 51

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Fluorescence image screening for chemical compounds modifying cholesterol metabolism and distribution

Ishitsuka, Reiko, Saito, Tamio, Osada, Hiroyuki, Ohno-Iwashita, Yoshiko, Kobayashi, Toshihide·2011·Journal of Lipid Research

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1194/jlr.d018184

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 44

  1. Simons, 2004, Model systems, lipid rafts, and cell membranes, Annu. Rev. Biophys. Biomol. Struct., 33, 269, 10.1146/annurev.biophys.32.110601.141803 · DOI
  2. Epand, 2010, Cholesterol interaction with proteins that partition into membrane domains: an overview, Subcell. Biochem., 51, 253, 10.1007/978-90-481-8622-8_9 · DOI
  3. Simons, 2000, Lipid rafts and signal transduction, Nat. Rev. Mol. Cell Biol., 1, 31, 10.1038/35036052 · DOI · Paper page
  4. Goldstein, 2006, Protein sensors for membrane sterols, Cell., 124, 35, 10.1016/j.cell.2005.12.022 · DOI · Paper page
  5. Ikonen, 2008, Cellular cholesterol trafficking and compartmentalization, Nat. Rev. Mol. Cell Biol., 9, 125, 10.1038/nrm2336 · DOI
  6. Maxfield, 2010, Cholesterol, the central lipid of mammalian cells, Curr. Opin. Cell Biol., 22, 422, 10.1016/j.ceb.2010.05.004 · DOI · Paper page
  7. Mesmin, 2009, Intracellular sterol dynamics, Biochim. Biophys. Acta., 1791, 636, 10.1016/j.bbalip.2009.03.002 · DOI
  8. Daniels, 2009, Lipoproteins, cholesterol homeostasis and cardiac health, Int. J. Biol. Sci., 5, 474, 10.7150/ijbs.5.474 · DOI
  9. Barrios-González, 2010, Biotechnological production and applications of statins, Appl. Microbiol. Biotechnol., 85, 869, 10.1007/s00253-009-2239-6 · DOI
  10. Pipalia, 2006, Automated microscopy screening for compounds that partially revert cholesterol accumulation in Niemann-Pick C cells, J. Lipid Res., 47, 284, 10.1194/jlr.M500388-JLR200 · DOI
  11. Severs, 1997, Cholesterol cytochemistry in cell biology and disease, Subcell. Biochem., 28, 477, 10.1007/978-1-4615-5901-6_16 · DOI
  12. Rujoi, 2010, Cholesterol pathways affected by small molecules that decrease sterol levels in Niemann-Pick type C mutant cells, PLoS ONE., 5, e12788, 10.1371/journal.pone.0012788 · DOI
  13. Ohno-Iwashita, 2010, Cholesterol-binding toxins and anti-cholesterol antibodies as structural probes for cholesterol localization, Subcell. Biochem., 51, 597, 10.1007/978-90-481-8622-8_22 · DOI
  14. Ohno-Iwashita, 2004, Perfringolysin O, a cholesterol-binding cytolysin, as a probe for lipid rafts, Anaerobe., 10, 125, 10.1016/j.anaerobe.2003.09.003 · DOI
  15. Nelson, 2008, How interaction of perfringolysin O with membranes is controlled by sterol structure, lipid structure, and physiological low pH: insights into the origin of perfringolysin O-lipid raft interaction, J. Biol. Chem., 283, 4632, 10.1074/jbc.M709483200 · DOI
  16. Shimada, 2002, The C-terminal domain of perfringolysin O is an essential cholesterol-binding unit targeting to cholesterol-rich microdomains, Eur. J. Biochem., 269, 6195, 10.1046/j.1432-1033.2002.03338.x · DOI
  17. Norman, 1972, Studies on the biological properties of polyene antibiotics. Evidence for the direct interaction of filipin with cholesterol, J. Biol. Chem., 247, 1918, 10.1016/S0021-9258(19)45558-0 · DOI
  18. Cruz, 2000, Fate of endogenously synthesized cholesterol in Niemann-Pick type C1 cells, J. Biol. Chem., 275, 41309, 10.1074/jbc.M008272200 · DOI
  19. Heino, 2000, Dissecting the role of the golgi complex and lipid rafts in biosynthetic transport of cholesterol to the cell surface, Proc. Natl. Acad. Sci. USA., 97, 8375, 10.1073/pnas.140218797 · DOI
  20. Mizuno, 2011, Fluorescent probes for superresolution imaging of lipid domains on the plasma membrane, Chem. Sci., 2, 1548, 10.1039/c1sc00169h · DOI
  21. Kobayashi, 1999, Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport, Nat. Cell Biol., 1, 113, 10.1038/10084 · DOI
  22. Cenedella, 2009, Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes, Lipids., 44, 477, 10.1007/s11745-009-3305-7 · DOI
  23. Liscum, 1989, The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one, J. Biol. Chem., 264, 11796, 10.1016/S0021-9258(18)80136-3 · DOI
  24. Klingenstein, 2006, Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments, J. Neurochem., 98, 748, 10.1111/j.1471-4159.2006.03889.x · DOI
  25. Roff, 1991, Type C Niemann-Pick disease: use of hydrophobic amines to study defective cholesterol transport, Dev. Neurosci., 13, 315, 10.1159/000112179 · DOI
  26. Palmeri, 1995, Amiodarone induced lipidosis similar to Niemann-Pick C disease. Biochemical and morphological study, Life Sci., 57, 1963, 10.1016/0024-3205(95)02129-7 · DOI
  27. Shayman, 2010, Group XV phospholipase A, a lysosomal phospholipase A, Prog. Lipid Res., 50, 1, 10.1016/j.plipres.2010.10.006 · DOI
  28. Zidovetzki, 2007, Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies, Biochim. Biophys. Acta., 1768, 1311, 10.1016/j.bbamem.2007.03.026 · DOI
  29. Nakamura, 1995, Characterization of a cis-Golgi matrix protein, GM130, J. Cell Biol., 131, 1715, 10.1083/jcb.131.6.1715 · DOI
  30. Kobayashi, 2000, The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells, Mol. Biol. Cell., 11, 1829, 10.1091/mbc.11.5.1829 · DOI
  31. Aikawa, 1994, Structure-specific inhibition of lysosomal cholesterol transport in macrophages by various steroids, Biochim. Biophys. Acta., 1213, 127, 10.1016/0005-2760(94)90018-3 · DOI
  32. Butler, 1992, Progesterone blocks cholesterol translocation from lysosomes, J. Biol. Chem., 267, 23797, 10.1016/S0021-9258(18)35908-8 · DOI
  33. Dröse, 1993, Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases, Biochemistry., 32, 3902, 10.1021/bi00066a008 · DOI
  34. Furuchi, 1993, Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, blocks lysosomal cholesterol trafficking in macrophages, J. Biol. Chem., 268, 27345, 10.1016/S0021-9258(19)74255-0 · DOI
  35. Issandou, 2004, Up-regulation of low-density lipoprotein receptor in human hepatocytes is induced by sequestration of free cholesterol in the endosomal/lysosomal compartment, Biochem. Pharmacol., 67, 2281, 10.1016/j.bcp.2004.03.006 · DOI
  36. Lange, 2002, Dynamics of lysosomal cholesterol in Niemann-Pick type C and normal human fibroblasts, J. Lipid Res., 43, 198, 10.1016/S0022-2275(20)30161-9 · DOI
  37. Raeder, 2006, Antidepressant drugs activate SREBP and up-regulate cholesterol and fatty acid biosynthesis in human glial cells, Neurosci. Lett., 395, 185, 10.1016/j.neulet.2005.10.096 · DOI
  38. Raeder, 2006, SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects?, Mol. Cell. Biochem., 289, 167, 10.1007/s11010-006-9160-4 · DOI
  39. Cavenee, 1978, Regulation of cholesterol biosynthesis in HeLa S3G cells by serum lipoproteins: dexamethasone-mediated interference with suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase, Proc. Natl. Acad. Sci. USA., 75, 2103, 10.1073/pnas.75.5.2103 · DOI
  40. Johnston, 1980, Glucocorticoid effects on lipid metabolism in HeLa cells: inhibition of cholesterol synthesis and increased sphingomyelin synthesis, Endocrinology., 107, 1482, 10.1210/endo-107-5-1482 · DOI
  41. Mark, 1996, Effects of a novel 2,3-oxidosqualene cyclase inhibitor on the regulation of cholesterol biosynthesis in HepG2 cells, J. Lipid Res., 37, 148, 10.1016/S0022-2275(20)37643-4 · DOI
  42. Sexton, 1983, Effects of 3 beta-[2-(diethylamino)ethoxy]androst-5-en-17-one on the synthesis of cholesterol and ubiquinone in rat intestinal epithelial cell cultures, Biochemistry., 22, 5687, 10.1021/bi00294a001 · DOI
  43. Holleran, 1998, Effect of tamoxifen on cholesterol synthesis in HepG2 cells and cultured rat hepatocytes, Metabolism., 47, 1504, 10.1016/S0026-0495(98)90078-6 · DOI
  44. Kedjouar, 2004, Molecular characterization of the microsomal tamoxifen binding site, J. Biol. Chem., 279, 34048, 10.1074/jbc.M405230200 · DOI

Cited by

Sorted by citations

Metadata

Authors
Ishitsuka, R., Saito, T., Osada, H., Ohno-Iwashita, Y., & Kobayashi, T.
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2011-11
Volume
52
Issue
11
Pages
2084-2094
ISSN
0022-2275
Cited by
51
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review